A single mutation that results in an Asp to His substitution and partial exon skipping in a family with congenital contractural arachnodactyly
暂无分享,去创建一个
[1] M. Raghunath,et al. A rare branch-point mutation is associated with missplicing of fibrillin-2 in a large family with congenital contractural arachnodactyly. , 1997, American journal of human genetics.
[2] R. Hennekam,et al. Parental somatic and germ-line mosaicism for a FBN2 mutation and analysis of FBN2 transcript levels in dermal fibroblasts. , 1997, American journal of human genetics.
[3] D. Reinhardt,et al. Calcium Stabilizes Fibrillin-1 against Proteolytic Degradation* , 1997, The Journal of Biological Chemistry.
[4] C. Clericuzio,et al. Familial occurrence of typical and severe lethal congenital contractural arachnodactyly caused by missplicing of exon 34 of fibrillin-2. , 1996, American journal of human genetics.
[5] U. Francke,et al. Mutant fibrillin-1 monomers lacking EGF-like domains disrupt microfibril assembly and cause severe marfan syndrome. , 1996, Human molecular genetics.
[6] Sarah Baatout,et al. Short protocols in molecular biology (3rd edn): by Frederick M. Ausubel, Roger Brent, Robert E. Kingston, David D. Moore, J.G. Seidman, John A. Smith and Kevin Struhl Wiley, 1995. £60.00/$90.00 pbk (750 pages) ISBN 0 47 113781 2 , 1996 .
[7] I. Campbell,et al. Solution Structure of a Pair of Calcium-Binding Epidermal Growth Factor-like Domains: Implications for the Marfan Syndrome and Other Genetic Disorders , 1996, Cell.
[8] P. Handford,et al. Calcium binding properties of an epidermal growth factor-like domain pair from human fibrillin-1. , 1996, Journal of molecular biology.
[9] D. Milewicz,et al. Fibrillin–2 (FBN2) mutations result in the Marfan–like disorder, congenital contractural arachnodactyly , 1995, Nature Genetics.
[10] P. Handford,et al. The structure of a Ca2+-binding epidermal growth factor-like domain: Its role in protein-protein interactions , 1995, Cell.
[11] P. Handford,et al. The Calcium Binding Properties and Molecular Organization of Epidermal Growth Factor-like Domains in Human Fibrillin-1 (*) , 1995, The Journal of Biological Chemistry.
[12] J. Berg,et al. Fibrillin domain folding and calcium binding: significance to Marfan syndrome. , 1995, Chemistry & biology.
[13] R. Glanville,et al. Calcium binding, hydroxylation, and glycosylation of the precursor epidermal growth factor-like domains of fibrillin-1, the Marfan gene protein. , 1994, The Journal of biological chemistry.
[14] U. Francke,et al. Quantitative differences in biosynthesis and extracellular deposition of fibrillin in cultured fibroblasts distinguish five groups of Marfan syndrome patients and suggest distinct pathogenetic mechanisms. , 1994, The Journal of clinical investigation.
[15] R. Mecham,et al. Structure and expression of fibrillin-2, a novel microfibrillar component preferentially located in elastic matrices , 1994, The Journal of cell biology.
[16] C. Kielty,et al. The role of calcium in the organization of fibrillin microfibrils , 1993, FEBS letters.
[17] U. Francke,et al. Missense mutations impair intracellular processing of fibrillin and microfibril assembly in Marfan syndrome. , 1993, Human molecular genetics.
[18] U. Francke,et al. Mutation screening of complete fibrillin-1 coding sequence: report of five new mutations, including two in 8-cysteine domains. , 1993, Human molecular genetics.
[19] B. Sykes,et al. Genomic organization of the sequence coding for fibrillin, the defective gene product in Marfan syndrome. , 1993, Human molecular genetics.
[20] H. Dietz,et al. Four novel FBN1 mutations: significance for mutant transcript level and EGF-like domain calcium binding in the pathogenesis of Marfan syndrome. , 1993, Genomics.
[21] H. Dietz,et al. Fibrillin binds calcium and is coded by cDNAs that reveal a multidomain structure and alternatively spliced exons at the 5' end. , 1993, Genomics.
[22] B. Sykes,et al. A novel fibrillin mutation in the Marfan syndrome which could disrupt calcium binding of the epidermal growth factor-like module. , 1993, Human molecular genetics.
[23] D. Viljoen,et al. Genetic linkage of the Marfan syndrome, ectopia lentis, and congenital contractural arachnodactyly to the fibrillin genes on chromosomes 15 and 5. The International Marfan Syndrome Collaborative Study. , 1992, The New England journal of medicine.
[24] M. Patterson,et al. Cardiac anomalies complicating congenital contractural arachnodactyly. , 1991, Archives of disease in childhood.
[25] M. Mattei,et al. Linkage of Marfan syndrome and a phenotypically related disorder to two different fibrillin genes , 1991, Nature.
[26] R. Glanville,et al. Partial sequence of a candidate gene for the Marfan syndrome , 1991, Nature.
[27] I. D. Campbell,et al. Key residues involved in calcium-binding motifs in EGF-like domains , 1991, Nature.
[28] S. Linse,et al. Calcium binding to the isolated beta-hydroxyaspartic acid-containing epidermal growth factor-like domain of bovine factor X. , 1989, The Journal of biological chemistry.
[29] G. Landes,et al. Beta-hydroxyaspartic acid in the first epidermal growth factor-like domain of protein C. Its role in Ca2+ binding and biological activity. , 1988, The Journal of biological chemistry.
[30] W. Schneider,et al. beta-Hydroxyaspartic acid or beta-hydroxyasparagine in bovine low density lipoprotein receptor and in bovine thrombomodulin. , 1988, The Journal of biological chemistry.
[31] J. Opitz,et al. A severe form of congenital contractural arachnodactyly in two newborn infants. , 1986, American journal of medical genetics.
[32] R. K. Beals,et al. Congenital contractural arachnodactyly Report of four additional families and review of literature , 1985, Clinical genetics.
[33] J. Opitz,et al. Cardiovascular findings in congenital contractural arachnodactyly: report of an affected kindred. , 1984, American journal of medical genetics.
[34] P. Macleod,et al. Congenital contractural arachnodactyly. A heritable disorder of connective tissue distinct from Marfan syndrome. , 1973, American journal of diseases of children.
[35] F. Hecht,et al. "New" syndrome of congenital contractural arachnodactyly originally described by Marfan in 1896. , 1972, Pediatrics.
[36] D. Stuart,et al. The structure of a Ca(2+)-binding epidermal growth factor-like domain: its role in protein-protein interactions. , 1995, Cell.
[37] C. Bottema,et al. [45] – Polymerase Chain Reaction Amplification of Specific Alleles: A General Method of Detection of Mutations, Polymorphisms, and Haplotypes , 1995 .
[38] C. Bottema,et al. Polymerase chain reaction amplification of specific alleles: a general method of detection of mutations, polymorphisms, and haplotypes. , 1993, Methods in Enzymology.
[39] B. Dahlbäck,et al. beta-Hydroxyasparagine in domains homologous to the epidermal growth factor precursor in vitamin K-dependent protein S. , 1987, Proceedings of the National Academy of Sciences of the United States of America.